122 related articles for article (PubMed ID: 2877867)
21. Regional expression of multidrug resistance genes in genetically epilepsy-prone rat brain after a single audiogenic seizure.
Kwan P; Sills GJ; Butler E; Gant TW; Meldrum BS; Brodie MJ
Epilepsia; 2002 Nov; 43(11):1318-23. PubMed ID: 12423380
[TBL] [Abstract][Full Text] [Related]
22. Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9s).
Statnick MA; Dailey JW; Jobe PC; Browning RA
Neuropharmacology; 1996 Jan; 35(1):111-8. PubMed ID: 8684590
[TBL] [Abstract][Full Text] [Related]
23. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat.
Lasley SM
Brain Res; 1991 Sep; 560(1-2):63-70. PubMed ID: 1684733
[TBL] [Abstract][Full Text] [Related]
24. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat.
Dailey JW; Reigel CE; Mishra PK; Jobe PC
Epilepsy Res; 1989; 3(1):3-17. PubMed ID: 2563686
[TBL] [Abstract][Full Text] [Related]
25. Alterations in brain and pituitary beta-endorphin content in genetically epilepsy-prone rats.
Carr JA; Carpenter AM; D'Souza MM; Elmore AR; Lovering AT; Reigel CE
Epilepsy Res; 1998 Jul; 31(2):113-22. PubMed ID: 9714502
[TBL] [Abstract][Full Text] [Related]
26. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats.
Statnick MA; Dailey JW; Jobe PC; Browning RA
Epilepsia; 1996 Apr; 37(4):311-21. PubMed ID: 8603634
[TBL] [Abstract][Full Text] [Related]
27. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis.
Yan QS; Jobe PC; Dailey JW
Brain Res; 1993 Apr; 610(1):24-31. PubMed ID: 8518928
[TBL] [Abstract][Full Text] [Related]
28. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs.
Reigel CE; Dailey JW; Jobe PC
Life Sci; 1986 Sep; 39(9):763-74. PubMed ID: 3747727
[TBL] [Abstract][Full Text] [Related]
29. Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRs.
Clough R; Statnick M; Maring-Smith M; Wang C; Eells J; Browning R; Dailey J; Jobe P
Neuroreport; 1996 Dec; 8(1):341-6. PubMed ID: 9051807
[TBL] [Abstract][Full Text] [Related]
30. Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat.
Hara M; Sasa M; Kawabata A; Serikawa T; Yamada T; Yamada J; Takaori S
Epilepsia; 1993; 34(3):433-40. PubMed ID: 8504778
[TBL] [Abstract][Full Text] [Related]
31. Intracerebral grafting of fetal dorsal pons in genetically epilepsy-prone rats: effects on audiogenic-induced seizures.
Clough RW; Browning RA; Maring ML; Jobe PC
Exp Neurol; 1991 May; 112(2):195-9. PubMed ID: 1674695
[TBL] [Abstract][Full Text] [Related]
32. Audiogenic seizure severity and hearing deficits in the genetically epilepsy-prone rat.
Faingold CL; Walsh EJ; Maxwell JK; Randall ME
Exp Neurol; 1990 Apr; 108(1):55-60. PubMed ID: 2318288
[TBL] [Abstract][Full Text] [Related]
33. Brainstem seizure severity regulates forebrain seizure expression in the audiogenic kindling model.
Merrill MA; Clough RW; Jobe PC; Browning RA
Epilepsia; 2005 Sep; 46(9):1380-8. PubMed ID: 16146432
[TBL] [Abstract][Full Text] [Related]
34. Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues.
Ryu JR; Jobe PC; Milbrandt JC; Mishra PK; Clough RW; Browning RA; Dailey JW; Seo DO; Ko KH
Exp Neurol; 1999 Mar; 156(1):84-91. PubMed ID: 10192779
[TBL] [Abstract][Full Text] [Related]
35. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities in the central cholinergic transmitter system of the genetically epilepsy-prone rat.
Laird HE; Hadjiconstantinou M; Neff NH
Life Sci; 1986 Sep; 39(9):783-7. PubMed ID: 3018414
[TBL] [Abstract][Full Text] [Related]
37. Decrease in locus coeruleus [3H]idazoxan binding site density in genetically epilepsy-prone (GEPR) rats.
Razani-Boroujerdi S; Tso-Olivas DY; Hoffman TJ; Weiss GK; Savage DD
Brain Res; 1993 Jan; 600(2):181-6. PubMed ID: 8094641
[TBL] [Abstract][Full Text] [Related]
38. Neuronal networks in the genetically epilepsy-prone rat.
Faingold CL
Adv Neurol; 1999; 79():311-21. PubMed ID: 10514823
[TBL] [Abstract][Full Text] [Related]
39. Neurotransmitter abnormalities in genetically epileptic rodents.
Laird HE; Dailey JW; Jobe PC
Fed Proc; 1984 Jul; 43(10):2505-9. PubMed ID: 6145625
[TBL] [Abstract][Full Text] [Related]
40. Fos expression and 2-deoxyglucose uptake following seizures in developing genetically epilepsy-prone rats.
Eells JB; Clough RW; Miller JW; Jobe PC; Browning RA
Brain Res Bull; 2000 Jul; 52(5):379-89. PubMed ID: 10922517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
